| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.32 | 9e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.3 | 2e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-05 |